Main > ONCOLOGY (**) > Liver Cancer *** > Treatment. > USA. M. HCC>TREAT.>PembrolizuMAb

---

USA. M. HCC>TREAT.>PembrolizuMAb's subsections
(*) USA Approval Date: 2018. 11.09.
>Previously Treated with Sorafenib
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2018. 11.06.
TradeMark
TradeMark Web-Site

USA. M. HCC>TREAT.>PembrolizuMAb's products
This section has no products